Breaking News - The Fly

Open Search

IMMX

Immix Biopharma

$

()

Immix Biopharma says 'on track' to dose NXC-201 patients in U.S.

IMMX

4/18/2024 - 09:33am

Immix announces Memorial Sloan Kettering as lead site for NXC-201 trial

IMMX

3/20/2024 - 09:49am

Immix Biopharma: EC grants orphan drug designation to NXC-201

IMMX

2/7/2024 - 09:39am

Immix Biopharma 5.5M share priced at $2.71

IMMX

2/6/2024 - 08:04am

Immix Biopharma announces common stock offering, no amount given

IMMX

2/5/2024 - 15:21pm

Immix Biopharma 'applauds' FDA labeling change notification for CAR-T products

IMMX

1/24/2024 - 08:38am

Three new option listings on January 24th

IMMX , MYO , NPCE

1/24/2024 - 08:30am

Immix Biopharma reports 100% ORR for CAR-T NXC-201 in r/r AL amyloidosis

IMMX

12/11/2023 - 09:39am

Immix Biopharma to hold virtual investor day

IMMX

11/29/2023 - 16:00pm

Immix Biopharma to hold virtual investor day

IMMX

11/29/2023 - 10:16am

Immix Biopharma announces FDA approval of IND application for NXC-201

IMMX

11/21/2023 - 09:49am

Immix Biopharma completes third NXC-201 engineering batch

IMMX

10/16/2023 - 09:09am

Immix Biopharma announces complete response in patient in NXC-201 trial

IMMX

10/3/2023 - 09:18am

Immix Biopharma announces 72-patient NXC-201 clinical data

IMMX

10/2/2023 - 08:16am

Fly Intel: After-Hours Movers

PROF , GRIN , SPRY

…

9/25/2023 - 18:25pm